Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Sartorius, Tina ^a,b   Staiger, Harald ^a,b   Ketterer, Caroline ^a,b   Heni, Martin ^a   Machicao, Fausto ^a,b   Guilherme, Adilson ^c   Grallert, Harald ^b,d   Schulze, Matthias B ^b,e   Boeing, Heiner ^b,e   Stefan, Norbert ^a,b   Fritsche, Andreas ^a,b   Czech, Michael P ^c   Häring, Hans Ulrich ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MAP4K4 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; GENETIC LOCI; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDIABETIC STATE; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84867660167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047647     Document Type: Article

References (27)

1. Muoio DM, Newgard CB, (2008) Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9: 193-205.
2. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929.
3. Perry JR, Frayling TM, (2008) New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 11: 371-377.
4. Staiger H, Machicao F, Fritsche A, Haring HU, (2009) Pathomechanisms of type 2 diabetes genes. Endocr Rev 30: 557-585.
5. Haupt A, Guthoff M, Schafer SA, Kirchhoff K, Machicao F, et al. (2009) The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. J Clin Endocrinol Metab 94: 1775-1780.
6. Jin W, Patti ME, (2009) Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin Sci (Lond) 116: 99-111.
7. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.
8. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28: 1304-1310.
9. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914-920.
10. Olefsky JM, Glass CK, (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72: 219-246.
11. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, et al. (1996) Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97: 1471-1477.
12. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
13. Yao Z, Zhou G, Wang XS, Brown A, Diener K, et al. (1999) A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J Biol Chem 274: 2118-2125.
14. Tesz GJ, Guilherme A, Guntur KV, Hubbard AC, Tang X, et al. (2007) Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J Biol Chem 282: 19302-19312.
15. Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, et al. (2006) An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport. Proc Natl Acad Sci U S A 103: 2087-2092.
16. Bouzakri K, Zierath JR, (2007) MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance. J Biol Chem 282: 7783-7789.
17. Stefan N, Machicao F, Staiger H, Machann J, Schick F, et al. (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48: 2282-2291.
18. Boeing H, Wahrendorf J, Becker N, (1999) EPIC-Germany-A source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 195-204.
19. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, et al. (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57: 2762-2767.
20. Baecke JA, Burema J, Frijters JE, (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36: 936-942.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
22. Matsuda M, DeFronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
23. Herzberg-Schafer SA, Staiger H, Heni M, Ketterer C, Guthoff M, et al. (2010) Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired beta-cell function. PLoS One 5: e14194.
24. American Diabetes Association, (2011) Diagnosis and classification of diabetes mellitus. Diabetes Care 34Suppl 1: S62-S69.
25. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, et al. (2009) Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 458: 1180-1184.
26. Bouzakri K, Ribaux P, Halban PA, (2009) Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion. J Biol Chem 284: 27892-27898.
27. Bouzakri K, Plomgaard P, Berney T, Donath MY, Pedersen BK, et al. (2011) Bimodal Effect on Pancreatic {beta}-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle. Diabetes 60: 1111-1121.